Northwest & Ethical Investments L.P. Acquires 1,520 Shares of Danaher Corporation $DHR

Key Points

• Northwest & Ethical Investments L.P. increased its holdings in Danaher Corporation by 42% by acquiring 1,520 shares, bringing their total ownership to 5,140 shares valued at $1,054,000.
• Multiple hedge funds, including GHP Investment Advisors Inc. and Dunhill Financial LLC, also raised or initiated positions in Danaher, indicating a strong interest among institutional investors which now collectively own 79.05% of the stock.
• Analysts have a consensus rating of "Moderate Buy" for Danaher, with an average price target of $247.61, despite multiple price target adjustments from firms like JPMorgan and Deutsche Bank.

Northwest & Ethical Investments L.P. boosted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 42.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,140 shares of the conglomerate's stock after buying an additional 1,520 shares during the quarter. Northwest & Ethical Investments L.P.'s holdings in Danaher were worth $1,054,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. GHP Investment Advisors Inc. raised its position in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares during the last quarter. Heck Capital Advisors LLC purchased a new position in Danaher in the 4th quarter worth about $27,000. Sierra Ocean LLC raised its position in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher in the 1st quarter worth about $31,000. Finally, Dunhill Financial LLC raised its position in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of several research reports. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Jefferies Financial Group reduced their price target on shares of Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research report on Tuesday, April 22nd. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Finally, Leerink Partners upped their price target on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research report on Wednesday, April 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Trading Up 1.5%

Danaher stock opened at $212.2350 on Wednesday. The firm has a 50 day moving average of $200.33 and a 200 day moving average of $199.54. The firm has a market capitalization of $151.97 billion, a price-to-earnings ratio of 45.16, a P/E/G ratio of 2.92 and a beta of 0.73. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.